Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Heyman

Showing results (281-290 of 292) with videos related to

Pageof 30
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 9, 2004
Regulation of PPARgamma coactivator 1alpha (PGC-1alpha) signaling by an estrogen-related receptor alpha (ERRalpha) ligandPatricia J Willy, Ian R Murray, Jing Qian, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 22, 2004
Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscleVamsi K Mootha, Christoph Handschin, Dan Arlow, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 24, 2002
Identification of macrophage liver X receptors as inhibitors of atherosclerosisRajendra K Tangirala, Eric D Bischoff, Sean B Joseph, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2010
Synthesis and SAR of 2-aryl-3-aminomethylquinolines as agonists of the bile acid receptor TGR5Mark R Herbert, Dana L Siegel, Lena Staszewski, et al.
Genome Research|April 20, 1999
Genome-scale cloning and expression of individual open reading frames using topoisomerase I-mediated ligationJ A Heyman, J Cornthwaite, L Foncerrada, et al.
Nature|February 14, 2020
MAFG-driven astrocytes promote CNS inflammationMichael A Wheeler, Iain C Clark, Emily C Tjon, et al.
Scientific Reports|January 3, 2026
A droplet microfluidics-based platform for generating target-specific, natively-paired immune libraries and identifying potent and developable antibodiesAnusuya Ramasubramanian, Brendan T Deveney, Sarah A Clark, et al.
Journal of Medicinal Chemistry|June 13, 2003
Novel (2E,4E,6Z)-7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta-2,4,6-trienoic acid retinoid X receptor modulators are active in models of type 2 diabetesP Y Michellys, R J Ardecky, J H Chen, et al.
Endocrinology|November 5, 2005
Biological characterization of a heterodimer-selective retinoid X receptor modulator: potential benefits for the treatment of type 2 diabetesMark D Leibowitz, Robert J Ardecky, Marcus F Boehm, et al.
Cancer Research|January 24, 2012
ARN-509: a novel antiandrogen for prostate cancer treatmentNicola J Clegg, John Wongvipat, James D Joseph, et al.
Pageof 30

Showing results (281-290 of 292) with videos related to

Sort By:
Pageof 30
Proceedings of the National Academy of Sciences of the United States of America|June 9, 2004
Regulation of PPARgamma coactivator 1alpha (PGC-1alpha) signaling by an estrogen-related receptor alpha (ERRalpha) ligandPatricia J Willy, Ian R Murray, Jing Qian, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 22, 2004
Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscleVamsi K Mootha, Christoph Handschin, Dan Arlow, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 24, 2002
Identification of macrophage liver X receptors as inhibitors of atherosclerosisRajendra K Tangirala, Eric D Bischoff, Sean B Joseph, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2010
Synthesis and SAR of 2-aryl-3-aminomethylquinolines as agonists of the bile acid receptor TGR5Mark R Herbert, Dana L Siegel, Lena Staszewski, et al.
Genome Research|April 20, 1999
Genome-scale cloning and expression of individual open reading frames using topoisomerase I-mediated ligationJ A Heyman, J Cornthwaite, L Foncerrada, et al.
Nature|February 14, 2020
MAFG-driven astrocytes promote CNS inflammationMichael A Wheeler, Iain C Clark, Emily C Tjon, et al.
Scientific Reports|January 3, 2026
A droplet microfluidics-based platform for generating target-specific, natively-paired immune libraries and identifying potent and developable antibodiesAnusuya Ramasubramanian, Brendan T Deveney, Sarah A Clark, et al.
Journal of Medicinal Chemistry|June 13, 2003
Novel (2E,4E,6Z)-7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta-2,4,6-trienoic acid retinoid X receptor modulators are active in models of type 2 diabetesP Y Michellys, R J Ardecky, J H Chen, et al.
Endocrinology|November 5, 2005
Biological characterization of a heterodimer-selective retinoid X receptor modulator: potential benefits for the treatment of type 2 diabetesMark D Leibowitz, Robert J Ardecky, Marcus F Boehm, et al.
Cancer Research|January 24, 2012
ARN-509: a novel antiandrogen for prostate cancer treatmentNicola J Clegg, John Wongvipat, James D Joseph, et al.
Pageof 30